CYP3A4 and metabolic dysfunction-associated steatotic liver disease: There is evidence that changes in hepatic levels of some miRNAs, in particular miR-150-5p and miR-200a-3p [141] in nonalcoholic fatty liver disease can post-transcriptionally modulate the expression of CYP3A4 [140,290,291,292].